Your browser doesn't support javascript.
loading
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.
Garcia-Manero, Guillermo; Montalban-Bravo, Guillermo; Berdeja, Jesus G; Abaza, Yasmin; Jabbour, Elias; Essell, James; Lyons, Roger M; Ravandi, Farhad; Maris, Michael; Heller, Brian; DeZern, Amy E; Babu, Sunil; Wright, David; Anz, Bertrand; Boccia, Ralph; Komrokji, Rami S; Kuriakose, Philip; Reeves, James; Sekeres, Mikkael A; Kantarjian, Hagop M; Ghalie, Richard; Roboz, Gail J.
Afiliação
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Berdeja JG; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Abaza Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Essell J; Oncology/Hematology Care, Cincinnati, Ohio.
  • Lyons RM; Cancer Care Center of South Texas, San Antonio, Texas.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Maris M; Colorado Blood Cancer Institute, Denver, Colorado.
  • Heller B; Southern Cancer Center, Daphne, Alabama.
  • DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.
  • Babu S; Fort Wayne Medical Oncology and Hematology, Fort Wain, Indiana.
  • Wright D; Florida Cancer Specialists-North, Jacksonville, Florida.
  • Anz B; Tennessee Oncology, Chattanooga, Tennessee.
  • Boccia R; Center for Cancer and Blood Disorders, Bethesda, Maryland.
  • Komrokji RS; H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Kuriakose P; Department of Internal Medicine, Division of Hematology Oncology, Henry Ford Hospital, Detroit, Michigan.
  • Reeves J; Florida Cancer Specialists-South, Cape Coral, Florida.
  • Sekeres MA; Leukemia Program, Cleveland Clinic, Cleveland, Ohio.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ghalie R; MEI Pharma, San Diego, California.
  • Roboz GJ; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical.
Cancer ; 123(6): 994-1002, 2017 May 15.
Article em En | MEDLINE | ID: mdl-28094841
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Protocolos de Quimioterapia Combinada Antineoplásica Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Protocolos de Quimioterapia Combinada Antineoplásica Idioma: En Ano de publicação: 2017 Tipo de documento: Article